# Evaluation of the In Vitro Permeation Parameters of Topical Diclofenac Sodium from Transdermal Pentravan® Products and Hydrogel Celugel Through Human Skin

**Authors:** Urszula Adamiak-Giera, Michał Gackowski, Joanna Szostak, Tomasz Osmałek, Damian Malinowski, Anna Nowak, Anna Machoy-Mokrzyńska, Maciej Miernik, Mirosław Halczak, Maciej Romanowski, Anna Czerkawska, Monika Białecka

PMC · DOI: 10.3390/ph18060810 · Pharmaceuticals · 2025-05-28

## TL;DR

This study compares the skin permeation of diclofenac sodium in homemade and commercial transdermal formulations to find safer and more effective pain relief options.

## Contribution

The study introduces a novel hydrogel-based formulation with absorption enhancers for improved topical diclofenac delivery.

## Key findings

- Celugel-based formulation with menthol showed better drug permeation than commercial products.
- The addition of absorption enhancers increased drug concentration in surrounding tissues.
- The new formulation may reduce adverse effects in elderly and polymedicated patients.

## Abstract

Background: Diclofenac is a phenylacetic acid derivative classified as a non-selective COX inhibitor. Similar to other NSAIDs, it is characterized by anti-inflammatory, antipyretic, and analgesic effects. Long-term therapy with diclofenac might also lead to severe gastrointestinal, renal, or cardiovascular systems disorders. Aim of the study was to compare own formulation prepared from pharmaceutical raw materials with ready-to-use diclofenac product. Methods: In the in vitro permeation experiments, human skin was excised from the abdomen of living patients as a result of plastic surgery. The transdermal semi-solid formulations were compounded using Pentravan®, a ready-to-use transdermal base and hydrophilic gel base (Celugel). In vitro Penetration Studies, HPLC analysis, optical microscopy imaging, and a spreadability test were conducted. Rheological analysis provided insights into flow behavior, structure, and thixotropy. Results: Combination of Celugel with diclofenac sodium and the addition of substances acting as absorption enhancers, e.g., menthol, may provide an interesting alternative for enteral drugs, especially in patients with multimorbidity and polypharmacy. Conclusions: Topical diclofenac sodium with of addition of permeation enhancers like menthol might provide higher drug concentrations in the surrounding tissues and better analgesic and anti-inflammatory effects in compare to commercially available product and may provide optimum effectiveness with minimal risk of adverse effects, particularly in elderly and polymedicated patients.

## Linked entities

- **Chemicals:** diclofenac sodium (PubChem CID 5018304), menthol (PubChem CID 1254)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** COX8A (cytochrome c oxidase subunit 8A) [NCBI Gene 1351] {aka COX, COX8, COX8-2, COX8L, MC4DN15, VIII}
- **Diseases:** inflammatory (MESH:D007249), gastrointestinal, renal, or cardiovascular systems disorders (MESH:D005767)
- **Chemicals:** phenylacetic acid (MESH:C025136), Celugel (-), menthol (MESH:D008610), Diclofenac (MESH:D004008)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12195876/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12195876/full.md

## References

32 references — full list in the complete paper: https://tomesphere.com/paper/PMC12195876/full.md

---
Source: https://tomesphere.com/paper/PMC12195876